Discovery of novel Macrocyclic small molecules Based on 2-Amino-4-thiazolylpyridineas selective EGFR inhibitors with high Blood-Brain barrier penetration for the treatment of glioblastoma

Authors:

Abstract
No abstract available
Funding Information
  • Guangzhou Municipal Science and Technology Bureau
  • Basic and Applied Basic Research Foundation of Guangdong Province (2023A1515011038)
  • Natural Science Foundation of Guangdong Province (2021A1515011246)

This publication has 31 references indexed in Scilit: